全文获取类型
收费全文 | 124317篇 |
免费 | 9802篇 |
国内免费 | 3486篇 |
专业分类
耳鼻咽喉 | 985篇 |
儿科学 | 2289篇 |
妇产科学 | 1774篇 |
基础医学 | 6944篇 |
口腔科学 | 2871篇 |
临床医学 | 14884篇 |
内科学 | 18350篇 |
皮肤病学 | 2304篇 |
神经病学 | 6357篇 |
特种医学 | 4040篇 |
外国民族医学 | 39篇 |
外科学 | 12154篇 |
综合类 | 18282篇 |
现状与发展 | 23篇 |
一般理论 | 2篇 |
预防医学 | 5113篇 |
眼科学 | 2039篇 |
药学 | 10561篇 |
73篇 | |
中国医学 | 11381篇 |
肿瘤学 | 17140篇 |
出版年
2024年 | 99篇 |
2023年 | 2156篇 |
2022年 | 3128篇 |
2021年 | 5156篇 |
2020年 | 5179篇 |
2019年 | 4632篇 |
2018年 | 4384篇 |
2017年 | 4880篇 |
2016年 | 5201篇 |
2015年 | 4955篇 |
2014年 | 9038篇 |
2013年 | 11490篇 |
2012年 | 7424篇 |
2011年 | 7917篇 |
2010年 | 6542篇 |
2009年 | 5996篇 |
2008年 | 5889篇 |
2007年 | 6327篇 |
2006年 | 5607篇 |
2005年 | 4986篇 |
2004年 | 4048篇 |
2003年 | 3667篇 |
2002年 | 2992篇 |
2001年 | 2641篇 |
2000年 | 2174篇 |
1999年 | 1682篇 |
1998年 | 1320篇 |
1997年 | 1101篇 |
1996年 | 900篇 |
1995年 | 903篇 |
1994年 | 707篇 |
1993年 | 538篇 |
1992年 | 482篇 |
1991年 | 444篇 |
1990年 | 378篇 |
1989年 | 331篇 |
1988年 | 325篇 |
1987年 | 274篇 |
1986年 | 219篇 |
1985年 | 257篇 |
1984年 | 229篇 |
1983年 | 166篇 |
1982年 | 167篇 |
1981年 | 165篇 |
1980年 | 129篇 |
1979年 | 123篇 |
1978年 | 67篇 |
1977年 | 43篇 |
1976年 | 52篇 |
1975年 | 33篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
BackgroundGlioma accounts for most central nervous system tumors, and the degree of invasion and malignancy are higher in the recurrent glioma. Photodynamic therapy (PDT) is an effective strategy in glioma. This study aimed to explore the risk factors for re-recurrence after a second glioma surgery and the effects of PDT on re-recurrence.MethodsThis was a retrospective study in the Second Affiliated Hospital of Harbin Medical University in China, and 43 patients that received the secondary surgery for recurrent glioma were included. The Kaplan-Meier test and Cox proportional hazard method were used to analyze.ResultsThe total re-recurrence rate after the second surgery for recurrent glioma was 48.84%. When the age increased by 1, the risk of re-recurrence increased 1.065 times (95% CI 1.000–1.134, P = 0.049). High matrix metalloproteinase (MMP) 2 expression was associated with a significantly higher risk of re-recurrence than low MMP2 expression (HR = 25.550, 95% CI 3.190–204.650, P = 0.002). Pathological grades IV and III were associated with a significantly higher risk of re-recurrence than pathological grade II (HR = 17.121, 95% CI 2.345–124.986, P = 0.005; HR = 2863.470, 95% CI 100.697–81,427.197, P < 0.001). PDT decreased the risk of re-recurrence (HR = 25.550, 95% CI 3.190–204.650, P = 0.002) and increased survival time (HR = 3.611, 95% CI 1.012–12.888, P = 0.048).ConclusionThe age, MMP2 expression, and pathological grade are independent risk factors for re-recurrence after a second surgery for recurrent glioma. PDT during the second surgery decreased the risk of re-recurrence and increased survival time. 相似文献
32.
33.
34.
35.
《Zeitschrift für medizinische Physik》2022,32(2):218-227
A magnetic resonance imaging (MRI) sequence independent deep learning technique was developed and validated to generate synthetic computed tomography (sCT) scans for MR guided proton therapy. 47 meningioma patients previously undergoing proton therapy based on pencil beam scanning were divided into training (33), validation (6), and test (8) cohorts. T1, T2, and contrast enhanced T1 (T1CM) MRI sequences were used in combination with the planning CT (pCT) data to train a 3D U-Net architecture with ResNet-Blocks. A hyperparameter search was performed including two loss functions, two group sizes of normalisation, and depth of the network. Training outcome was compared between models trained for each individual MRI sequence and for all sequences combined. The performance was evaluated based on a metric and dosimetric analysis as well as spot difference maps. Furthermore, the influence of immobilisation masks that are not visible on MRIs was investigated. Based on the hyperparameter search, the final model was trained with fixed features per group for the group normalisation, six down-convolution steps, an input size of 128 × 192 × 192, and feature loss. For the test dataset for body/bone the mean absolute error (MAE) values were on average 79.8/216.3 Houndsfield unit (HU) when trained using T1 images, 71.1/186.1 HU for T2, and 82.9/236.4 HU for T1CM. The structural similarity metric (SSIM) ranged from 0.95 to 0.98 for all sequences. The investigated dose parameters of the target structures agreed within 1% between original proton treatment plans and plans recalculated on sCTs. The spot difference maps had peaks at ±0.2 cm and for 98% of all spots the difference was less than 1 cm. A novel MRI sequence independent sCT generator was developed, which suggests that the training phase of neural networks can be disengaged from specific MRI acquisition protocols. In contrast to previous studies, the patient cohort consisted exclusively of actual proton therapy patients (i.e. “real-world data”). 相似文献
36.
《Nefrología : publicación oficial de la Sociedad Espa?ola Nefrologia》2022,42(2):145-162
Renal sodium and water retention with resulting extracellular volume expansion and redistribution are hallmark features of heart failure syndromes. However, congestion assessment, monitoring, and treatment represent a real challenge in daily clinical practice. This document reviewed historical and contemporary evidence of available methods for determining volume status and discuss pharmacological aspects and pathophysiological principles that underlie diuretic use. 相似文献
37.
《肿瘤代谢与营养电子杂志》2022,9(2):185-189
血液系统肿瘤患者诊治过程中普遍存在营养不良,化疗作为血液系统肿瘤最重要的治疗手段,进一步加剧患者的营养不
良,其最主要的原因是化疗引起的恶心、呕吐及摄食减少。诱导治疗后C反应蛋白的显著升高,提示感染发生率及炎症水平均较高,
这在一定程度上可能干扰机体代谢、加剧营养状态的恶化。血液系统肿瘤患者的营养不良表现为体质指数异常、人体成分异常、整体/
综合评估异常和生化指标异常。血液系统肿瘤患者营养治疗的原则与其他肿瘤类似,肠内营养为主,肠外营养为辅。但是,需要注意
补充特殊营养剂:①谷氨酰胺;②针对“粒细胞减少”的饮食;③ω‐3多不饱和脂肪酸;④牛初乳及大豆饮食。通过营养筛查和评估,为
处于不同治疗阶段的血液系统肿瘤患者制定营养治疗方案,及时、恰当地进行个体化营养治疗,可显著改善血液系统肿瘤患者营养状
况、预防营养不良及相关并发症,降低治疗相关不良反应风险,提高耐受性、疗效及生活质量。 相似文献
38.
39.
Laurien J. Zeverijn Eleonora J. Looze Subotheni Thavaneswaran J. Maxime van Berge Henegouwen Robert J. Simes Louisa R. Hoes Katrin M. Sjoquist Hanneke van der Wijngaart Lucille Sebastian Birgit S. Geurts Chee K. Lee Gijsbrecht F. de Wit David Espinoza Paul Roepman Frank P. Lin Anne M. L. Jansen Wendy W. J. de Leng Vincent van der Noort Lindsay V. M. Leek Filip Y. F. L. de Vos Carla M. L. van Herpen Hans Gelderblom Henk M. W. Verheul David M. Thomas Emile E. Voest 《International journal of cancer. Journal international du cancer》2023,153(7):1413-1422
The Dutch Drug Rediscovery Protocol (DRUP) and the Australian Cancer Molecular Screening and Therapeutic (MoST) Program are similar nonrandomized, multidrug, pan-cancer trial platforms that aim to identify signals of clinical activity of molecularly matched targeted therapies or immunotherapies outside their approved indications. Here, we report results for advanced or metastatic cancer patients with tumors harboring cyclin D-CDK4/6 pathway alterations treated with CDK4/6 inhibitors palbociclib or ribociclib. We included adult patients that had therapy-refractory solid malignancies with the following alterations: amplifications of CDK4, CDK6, CCND1, CCND2 or CCND3, or complete loss of CDKN2A or SMARCA4. Within MoST, all patients were treated with palbociclib, whereas in DRUP, palbociclib and ribociclib were assigned to different cohorts (defined by tumor type and alteration). The primary endpoint for this combined analysis was clinical benefit, defined as confirmed objective response or stable disease ≥16 weeks. We treated 139 patients with a broad variety of tumor types; 116 with palbociclib and 23 with ribociclib. In 112 evaluable patients, the objective response rate was 0% and clinical benefit rate at 16 weeks was 15%. Median progression-free survival was 4 months (95% CI: 3-5 months), and median overall survival 5 months (95% CI: 4-6 months). In conclusion, only limited clinical activity of palbociclib and ribociclib monotherapy in patients with pretreated cancers harboring cyclin D-CDK4/6 pathway alterations was observed. Our findings indicate that monotherapy use of palbociclib or ribociclib is not recommended and that merging data of two similar precision oncology trials is feasible. 相似文献